Related references
Note: Only part of the references are listed.Circulating Triacylglycerol Signatures in Nonalcoholic Fatty Liver Disease Associated With the I148M Variant in PNPLA3 and With Obesity
Jenni Hyysalo et al.
DIABETES (2014)
PNPLA3 I148M polymorphism and progressive liver disease
Paola Dongiovanni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls
Luca Valenti et al.
BMC GASTROENTEROLOGY (2012)
Increased Fetuin-A Concentrations in Impaired Glucose Tolerance with or without Nonalcoholic Fatty Liver Disease, But Not Impaired Fasting Glucose
Horng-Yih Ou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese
Yu Xu et al.
ATHEROSCLEROSIS (2011)
Meta-Analysis of the Influence of I148M Variant of Patatin-Like Phospholipase Domain Containing 3 Gene (PNPLA3) on the Susceptibility and Histological Severity of Nonalcoholic Fatty Liver Disease
Silvia Sookoian et al.
HEPATOLOGY (2011)
A catalogue of reporting guidelines for health research
I. Simera et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
I148M Patatin-Like Phospholipase Domain-Containing 3 Gene Variant and Severity of Pediatric Nonalcoholic Fatty Liver Disease
Luca Valenti et al.
HEPATOLOGY (2010)
Homozygosity for the Patatin-Like Phospholipase-3/Adiponutrin I148M Polymorphism Influences Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Luca Valenti et al.
HEPATOLOGY (2010)
Serum Fetuin-A is an Independent Marker of Insulin Resistance in Japanese Men
Ayako Ishibashi et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis
Yusuf Yilmaz et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2010)
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans
A. Kotronen et al.
DIABETOLOGIA (2009)
Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss
Thomas Reinehr et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production
Anita M. Hennige et al.
PLOS ONE (2008)
Fetuin-null mice are protected against obesity and insulin resistance associated with aging
Suresh T. Mathews et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Association between human fetuin-A and the metabolic syndrome - Data from the Heart and Soul Study
JH Ix et al.
CIRCULATION (2006)
α2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans
N Stefan et al.
DIABETES CARE (2006)
Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects
K Mori et al.
DIABETES CARE (2006)
A synonymous coding polymorphism in the α2-Heremans-Schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians
A Siddiq et al.
DIABETES (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Adiponectin and adiponectin receptors
T Kadowaki et al.
ENDOCRINE REVIEWS (2005)
α2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action
I Dahlman et al.
DIABETOLOGIA (2004)
Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A
B Denecke et al.
BIOCHEMICAL JOURNAL (2003)
Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene
ST Mathews et al.
DIABETES (2002)
α2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor
ST Mathews et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2000)
Share Paper
